The gut microbiota and the liver: implications for clinical practice

Area of Science:

• Gastroenterology and Hepatology
• Microbiology
• Immunology

Background:

• The microbiota's role in liver disease complications is established.
• Emerging evidence suggests a fundamental role in liver disease etiology.
• The precise impact of microbiota changes across liver disease stages requires further elucidation.

Purpose of the Study:

• To review the current understanding of the microbiota's role in liver disease.
• To highlight the need for clearer definitions of microbiota relevance in various liver disease forms.
• To assess the impact of interventions like antibiotics, probiotics, and fecal transplantation on microbiota-host interactions.

Main Methods:

• Literature review of existing clinical and laboratory data.
• Analysis of the impact of therapeutic interventions on the gut microbiota.
• Evaluation of the evidence supporting microbiota-targeted therapies.

Main Results:

• Antibiotic therapy is clinically supported for hepatic encephalopathy and spontaneous bacterial peritonitis.
• The impact of antibiotics on microbiota-host interactions remains poorly defined.
• Probiotics and fecal transplantation show promise, but high-quality clinical evidence is limited.

Conclusions:

• The microbiota's role in liver disease is complex and multifaceted.
• Further research is crucial to define the microbiota's precise impact on liver disease pathogenesis and progression.
• High-quality clinical trials are needed to validate microbiota-modulating therapies for liver disease management.